Answers are grounded in this paper and cite their sources.
The quality of life for a patient has been transformed in the last 15 years due to innovations that have resulted in better treatments for severe psoriasis, a chronic inflammatory cutaneous disease. Now, novel therapies for psoriasis need to reach a high standard in order to offer patients with psoriasis a genuine alternative. Here we outline a suggested critical checklist that will help industry sponsors, researchers, and clinicians evaluate novel therapeutics for psoriasis.
No takes yet. Share an insight, caveat, or question.
Yiu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: